Literature DB >> 1913429

Chlamydia trachomatis cervical infection: prevalence and determinants among women presenting for routine gynecologic examination.

R Massé1, H Laperrière, H Rousseau, J Lefebvre, R S Remis.   

Abstract

OBJECTIVE: To determine the prevalence of and risk indicators for Chlamydia trachomatis cervical infection among women presenting for a periodic medical examination.
DESIGN: Prevalence study.
SETTING: Centre local de services communautaires (CLSC) Saint-Louis du Parc, Montreal. PATIENTS: All women presenting for a routine gynecologic examination from May 1985 to July 1986. Of the 773 (99%) who agreed to participate 56 were excluded because of inadequate diagnostic tests (34), antibiotic intake in the preceding 6 weeks (19) or loss to follow-up after the initial visit (3). OUTCOME MEASURES: Culture was the diagnostic standard, but rapid diagnostic tests were also used. From the identified cases logistic regression analysis was used to evaluate the following risk indicators: age, place of residence, use of oral contraceptives, sexual partners and frequency, history of sexually transmitted disease (STD) and abnormalities found on genital examination. MAIN
RESULTS: Fifty-one of the women were found to have C. trachomatis infection, for a prevalence rate of 7.1%; 32 (63%) were completely asymptomatic. Three independent indicators were found: age of 25 years or less (odds ratio [OR] 3.2, 95% confidence limits [CL] 1.8 and 5.9), cervical erythema, contact bleeding or mucopurulent exudate (OR 2.5, 95% CL 1.4 and 4.5) and residency in the CLSC area (OR 2.3, 95% CL 1.1 and 5.1). A history of STD or vaginitis had a significant protective effect in women 30 years of age or more (OR 0.2).
CONCLUSIONS: Case-finding for chlamydial infection could be an effective public health measure among women 25 years of age or less and among those with signs of cervicitis when they present for a Papanicolaou test.

Entities:  

Mesh:

Year:  1991        PMID: 1913429      PMCID: PMC1335984     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  37 in total

1.  Dynamics and control of the transmission of gonorrhea.

Authors:  J A Yorke; H W Hethcote; A Nold
Journal:  Sex Transm Dis       Date:  1978 Apr-Jun       Impact factor: 2.830

2.  Early detection of genital chlamydial infection in women: an economic evaluation.

Authors:  A Estany; M Todd; M Vasquez; R McLaren
Journal:  Sex Transm Dis       Date:  1989 Jan-Mar       Impact factor: 2.830

3.  Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics.

Authors:  H H Handsfield; L L Jasman; P L Roberts; V W Hanson; R L Kothenbeutel; W E Stamm
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

4.  Measures to control Chlamydia trachomatis infections: an assessment of new national policy guidelines.

Authors:  W E Stamm; K K Holmes
Journal:  JAMA       Date:  1986-09-05       Impact factor: 56.272

5.  Endocervical Chlamydia trachomatis infection in Canadian adolescents.

Authors:  E G Hughes; J Mowatt; J E Spence
Journal:  CMAJ       Date:  1989-02-01       Impact factor: 8.262

6.  Cost-effectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases.

Authors:  M D Nettleman; R B Jones; S D Roberts; B P Katz; A E Washington; R S Dittus; T S Quinn
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

7.  Chlamydial infection among females attending an abortion clinic: prevalence and risk factors.

Authors:  P Levallois; J E Rioux; L Côté
Journal:  CMAJ       Date:  1987-07-01       Impact factor: 8.262

8.  Comparison of three techniques for detection of Chlamydia trachomatis in endocervical specimens from asymptomatic women.

Authors:  J Lefebvre; H Laperrière; H Rousseau; R Massé
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Cost-effectiveness of screening women at moderate risk for genital infections caused by Chlamydia trachomatis.

Authors:  M D Nettleman; R B Jones
Journal:  JAMA       Date:  1988-07-08       Impact factor: 56.272

10.  A cost-based decision analysis for Chlamydia screening in California family planning clinics.

Authors:  A I Trachtenberg; A E Washington; S Halldorson
Journal:  Obstet Gynecol       Date:  1988-01       Impact factor: 7.661

View more
  11 in total

Review 1.  Periodic health examination, 1992 update: 4. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

2.  Is oral contraceptive associated with genital warts?

Authors:  J D Ross
Journal:  Genitourin Med       Date:  1996-10

Review 3.  The role of epidemiology and surveillance systems in the control of sexually transmitted diseases.

Authors:  M A Catchpole
Journal:  Genitourin Med       Date:  1996-10

4.  Chlamydial cervicitis: testing the practice guidelines for presumptive diagnosis.

Authors:  J Sellors; M Howard; L Pickard; D Jang; J Mahony; M Chernesky
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

5.  Prevalence of cervical pathogens in women with and without inflammatory changes on smear testing.

Authors:  W L Parsons; M Godwin; C Robbins; R Butler
Journal:  BMJ       Date:  1993-05-01

6.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

7.  Risk factors for genital chlamydial infection.

Authors:  Christine Navarro; Anne Jolly; Rama Nair; Yue Chen
Journal:  Can J Infect Dis       Date:  2002-05

8.  Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region.

Authors:  Deirdre L Church; Ali Zentner; Heather Semeniuk; Elizabeth Henderson; Ron Read
Journal:  Can J Infect Dis       Date:  2003-01

9.  Chlamydia trachomatis infection in rural Nova Scotia.

Authors:  D B Langille; J Shoveller
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

10.  Screening guidelines for Chlamydia trachomatis infection. Evaluating physician awareness, agreement, and use.

Authors:  K Weyman; A R Lanning
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.